Comparing Atlantic International (ATLN) and Its Peers

Valuation and Earnings

This table compares Atlantic International and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Atlantic International	$80,000.00	-$5.63 million	-0.35
Atlantic International Competitors	$3.25 billion	$51.13 million	4.18

Atlantic International’s peers have higher revenue and earnings than Atlantic International. Atlantic International is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

Atlantic International has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Comparatively, Atlantic International’s peers have a beta of 1.14, meaning that their average stock price is 14% more volatile than the S&P 500.

Institutional and Insider Ownership

60.6% of shares of all “Help supply services” companies are owned by institutional investors. 22.3% of Atlantic International shares are owned by insiders. Comparatively, 16.9% of shares of all “Help supply services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Atlantic International and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Atlantic International	N/A	-298.20%	-42.32%
Atlantic International Competitors	-0.18%	16.54%	4.39%

Summary

Atlantic International peers beat Atlantic International on 6 of the 9 factors compared.

About Atlantic International

Atlantic International Corp. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones in 2013 and is headquartered in Billercia, MA.